Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist

Elisa Sanchez1, Morgan Huse2

  • 1Immunology Program, Memorial Sloan-Kettering Cancer Center; Weill-Cornell Graduate School of Medical Sciences.

Insights

Researchers developed a novel imaging method to study T cell activation. This technique uses photoactivatable peptide-MHC to precisely control T cell receptor signaling and visualize synapse formation.

Area of Science:

  • Immunology
  • Cell Biology
  • Biophysics

Background:

  • T lymphocytes exhibit rapid, polarized signaling upon T cell receptor (TCR) activation, leading to immunological synapse formation.
  • The immunological synapse is crucial for regulating T cell activation and directing effector responses.
  • Studying these rapid cellular dynamics requires advanced imaging techniques capable of capturing polarized events.

Purpose of the Study:

  • To describe an imaging system for precise spatiotemporal control of TCR activation.
  • To enable high-resolution monitoring of cellular responses during immunological synapse formation.
  • To facilitate the elucidation of molecular pathways linking TCR signaling to cytoskeletal organization.

Main Methods:

  • Utilizes a photoactivatable peptide-major histocompatibility complex (pMHC) that becomes stimulatory upon UV light exposure.
  • Employs targeted decaging of the pMHC reagent during videomicroscopy.
  • Integrates total internal reflection fluorescence (TIRF) imaging for high-resolution cellular monitoring.
  • Compatible with genetic and pharmacological perturbation strategies.

Main Results:

  • Precise spatiotemporal control over TCR activation was achieved.
  • High-resolution monitoring of cellular responses, including cytoskeletal rearrangements, was enabled.
  • The system allows for the assembly of molecular pathways involved in synapse formation.

Conclusions:

  • This photoactivatable pMHC-based imaging system provides a powerful tool for studying rapid T cell signaling and immunological synapse dynamics.
  • The approach offers precise control and high-resolution visualization, advancing our understanding of T cell activation.
  • It serves as a versatile platform for investigating molecular mechanisms underlying immune cell interactions.

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.0K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.0K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.6K